Interferon alpha-2a in the long term management of younger patients with essential thrombocythemia.

被引：0
|
作者：
Bentley, M
Taylor, K
Grigg, A
Kronenberg, H
Gibson, J
Baker, R
Bunce, I
Eliadis, P
Olsen, T
Frost, T
Wright, S
Taylor, D
Rodwell, R
Favot, P
McDacy, J
Rentoul, A
Kelley, C
机构：
[1] MATER MISERICORDIAE HOSP,DEPT HAEMATOL,BRISBANE,QLD,AUSTRALIA
[2] ROYAL MELBOURNE HOSP,DEPT HAEMATOL,MELBOURNE,VIC,AUSTRALIA
[3] ROYAL PRINCE ALFRED HOSP,INST HAEMATOL,SYDNEY,NSW,AUSTRALIA
[4] ROYAL PERTH HOSP,DEPT HAEMATOL,PERTH,WA,AUSTRALIA
[5] WESLEY MED CTR,CLIN HAEMATOL,BRISBANE,QLD,AUSTRALIA
[6] WESLEY MED CTR,CLIN ONCOL,BRISBANE,QLD,AUSTRALIA
[7] ROCHE PROD,SYDNEY,NSW,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1553 / 1553
页数：1
相关论文
共 50 条
  • [1] Interferon alpha treatment in 292 patients with Essential Thrombocythemia.
    Gugliotta, L
    Lazzarino, M
    [J]. BLOOD, 1996, 88 (10) : 2313 - 2313
  • [2] TREATMENT OF ESSENTIAL THROMBOCYTHEMIA BY ALPHA-2A INTERFERON
    BELLUCCI, S
    HAROUSSEAU, JL
    BRICE, P
    TOBELEM, G
    [J]. LANCET, 1988, 2 (8617): : 960 - 961
  • [3] Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment
    Ventroyen, B
    Vanstraelen, D
    [J]. ACTA HAEMATOLOGICA, 2002, 107 (03) : 158 - 169
  • [4] RECOMBINANT ALPHA-2A INTERFERON - AN EFFECTIVE MAINTENANCE AGENT IN ESSENTIAL THROMBOCYTHEMIA
    GILES, FJ
    ANDERSON, CC
    GRANT, IR
    HOFFBRAND, AV
    MEHTA, AB
    MACHIN, SJ
    GOLDSTONE, AH
    [J]. LEUKEMIA & LYMPHOMA, 1990, 3 (02) : 103 - 107
  • [5] LONG-TERM THERAPY WITH INTERFERON-ALPHA IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    WEHMEIER, A
    MEIERKORD, F
    SCHNEIDER, W
    [J]. BLOOD, 1994, 84 (10) : A58 - A58
  • [6] Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemia
    Bentley, M
    Taylor, K
    Grigg, A
    Kronenberg, H
    Gibson, J
    Bunce, I
    Eliadis, P
    Olsen, T
    Wright, S
    Taylor, D
    Rodwell, R
    [J]. LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 123 - 128
  • [7] INTERFERON ALPHA-2A TO CONTROL THROMBOCYTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA AND ESSENTIAL THROMBOCYTHEMIA
    JOOTAR, S
    [J]. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1989, 7 (02): : 103 - 105
  • [8] INTERFERON ALPHA-2B IN THE LONG-TERM TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
    SACCHI, S
    TABILIO, A
    LEONI, P
    RICCARDI, A
    VECCHI, A
    MESSORA, C
    FALZETTI, F
    RUPOLI, S
    UCCI, G
    MARTELLI, MF
    [J]. ANNALS OF HEMATOLOGY, 1991, 63 (04) : 206 - 209
  • [9] ALPHA-INTERFERON IN THE MANAGEMENT OF ESSENTIAL THROMBOCYTHEMIA
    GIRALT, M
    RUBIO, D
    CORTES, MT
    MIGUEL, JS
    STEEGMANN, JL
    SERENA, J
    FERNANDEZRANADA, JM
    LOPEZBORRASCA, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 : S72 - S74
  • [10] RECOMBINANT ALPHA-2A INTERFERON (ALPHA-IFN) IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA - PRELIMINARY-REPORT
    GUGLIOTTA, L
    MACCHI, S
    CATANI, L
    CHETTI, L
    BELMONTE, MM
    GUARINI, A
    CRISCUOLO, D
    TURA, S
    [J]. HAEMATOLOGICA, 1987, 72 (03) : 277 - 279
12345